Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178498 · ClinicalTrials.gov registry record
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
A clinical trial of Breast Carcinoma and Breast Lobular Carcinoma In Situ, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- 960
- Enrollment target
- 1
- Study location
NCT05178498: Recruiting study of Breast Carcinoma and Breast Lobular Carcinoma In Situ, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05178498 is a study of Breast Carcinoma and Breast Lobular Carcinoma In Situ that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 960 participants, above the 761-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05178498, a study of Breast Carcinoma and Breast Lobular Carcinoma In Situ, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 960 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Primary Outcome
Will be expressed as the means, medians and standard deviations (for continuous variables) or frequencies and percentages (for categorical variables). To assess the association of baseline Empirical Dietary Inflammatory pattern (EDIP) scores with breast cancer incidence, Cox proportional hazards regression will be used to estimate the hazard ratio (HR) and its 95% confidence interval (CI).
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Follow-Up
- PROCEDURE Physical Examination
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2023-10-25 |
| Est. Completion | 2035-12-31 |
What NCT05178498 shows while recruiting
NCT05178498 is an observational study that tracks outcomes without assigning an intervention. The registered 960 participants enrollment target is mid-sized for trials with a published cap, above the 761-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (26% higher).
The record links to 5 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05178498 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05178498 about?
NCT05178498 is a clinical study titled "Impact of Dietary Inflammatory Potential on Breast Cancer Risk". This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeu...
What is the current status of trial NCT05178498?
This trial is currently recruiting. The enrollment target is 960 participants. The study started on 2023-10-25. Estimated completion is 2035-12-31.
What conditions does trial NCT05178498 study?
This clinical trial studies the following conditions: Breast Carcinoma, Breast Lobular Carcinoma In Situ, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Sclerosing Adenosis.
What interventions are being tested in trial NCT05178498?
The interventions under investigation include: Questionnaire Administration (OTHER), Follow-Up (PROCEDURE), Physical Examination (PROCEDURE).
Who is sponsoring clinical trial NCT05178498?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178498 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05178498's enrollment target sits among peer trials
960 13th of 106 higher than 94 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
- NCT06764485 · 960 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI